Hege Sollie-Zetlmayer
Board Member
Ptc Therapeutics, Inc. (PTCT)Equibles does not estimate personal net worth.
Get an email with a short summary when Ptc Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get PTCT alertsAbout Hege Sollie-Zetlmayer
Hege Sollie-Zetlmayer is recorded as Board Member at Ptc Therapeutics, Inc. (PTCT) since July 28, 2026. Ptc Therapeutics, Inc. reported in an 8-K filed July 30, 2026 that Hege Sollie-Zetlmayer was appointed director, effective July 28, 2026. Ptc Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ptc Therapeutics, Inc. includes Dr. Matthew B. Klein (CEO and Board Member), Matthew B. Klein (CEO and Board Member), Matthew Klein (CEO and Board Member) and 7 others.
“On July 28, 2026, the Company appointed Hege Sollie-Zetlmayer to its board of directors (the "Board"), effective immediately, filling a vacancy on the Board.”
Affiliation history
-
Current
2026-07-28–present
Company network
Leadership on record at Ptc Therapeutics, Inc.
- Dr. Matthew B. Klein CEO, Board Member
- Matthew B. Klein CEO, Board Member
- Matthew Klein CEO, Board Member
- Michael Schmertzler CFO
- Mark E. Boulding General Counsel
- Christine Utter Chief Accounting Officer
- Allan Jacobson Board Member
- David P. Southwell Board Member
- Jessica Chutter Board Member
- William F. Bell Board Member